Mechanism of progression of neointimal hyperplasia at the vasada anastomatic strictwe : a study in tenascin-C Deficient Mice
Mechanism of progression of neointimal hyperplasia at the vasada anastomatic strictwe : a study in tenascin-C Deficient Mice
批准号:
14370409
负责人:
ONODA Koji
金额:
$3.78万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A simple aortotomy model was constructed using mice. In the wild-type mice, neointimal hyperplasia was observed at the suture sites at days 14 and 28. Immunohistochemical staining showed the strong expression of tenascin-C in both the neoinitima and media around the suture line at day 14. At day 28, tenascin-C staining was detected in the neointima, but not in the media. In the tenascin-C-deficient mice, much less neointimal hyperplasia was seen compared to in the wild-type mice and the mean neointima/media area ratio decreased to 45.4% and 30.5% at days 14 and 28, respectively. Proliferating cell nuclear antigen indeces in the wild-type mice were two times higher than those in the tenascin-C-deficient mice at day 14. Less alcian blue-positive proteoglycans were deposited in the neointima of the tenascin-C-deficient mice than the wild-type mice. These results suggest that tenascin-C promotes neointimal cell migration and proliferation, and deposition of proteoglycans. The current study provide direct evidence that tenascin-C is a key molecule in neointimal hyperplasia in anastomotic stenosis, implying its role as a target molecule for the prevention of stenosis.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ming Cai, et al.: "Degradation of Tenascin-C and Activity of Matrix Metalloproteinase -2 are Associated with Tunor Recarreuce in Early Stage Non-Small Cell Lung Cancer."Clinical Cancer Res.. 8. 1152-1156 (2002)
Ming Cai 等人:“腱蛋白-C 的降解和基质金属蛋白酶 -2 的活性与早期非小细胞肺癌中的肿瘤复发相关。”临床癌症研究 8. 1152-1156 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuya Fujinaga, et al.: "Locally applied alostazol sappresses necintomal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell preliferation in free astery grafo"J.Thorac.Cardiovar.Sorg.. in press. (2004)
Kazuya Fujinaga 等人:“局部应用阿洛他唑通过抑制游离 astery grafo 中生腱蛋白-C 合成和平滑肌细胞增殖来抑制坏死瘤增生”J.Thorac.Cardiovar.Sorg.. 正在出版。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuya Fujinaga: "Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts"J.Thorac.Cardiovasc.Surg.. (In press). (2004)
Kazuya Fujinaga:“局部应用西洛他唑通过抑制游离动脉移植物中生腱蛋白-C 合成和平滑肌细胞增殖来抑制新内膜增生”J.Thorac.Cardiovasc.Surg.(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ming Cai: "Degradation of Tenascin-C and Activity of Matrix Metalloproteinase-2 Are Associated with Tumor Recurrence in Early Stage Non-Small Cell Lung Cancer."Clinical Cancer Research. 8. 1152-1156 (2002)
蔡明:“腱蛋白-C 的降解和基质金属蛋白酶-2 的活性与早期非小细胞肺癌的肿瘤复发有关。”临床癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuya Fujinaga: "Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts."J.Thorac.Cardiovasc.Surg.. (in press). (2004)
Kazuya Fujinaga:“局部应用西洛他唑通过抑制游离动脉移植物中生腱蛋白-C 的合成和平滑肌细胞增殖来抑制新内膜增生。”J.Thorac.Cardiovasc.Surg.(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Activated Leukocyte-Endothelium Interactions during Ischemia Cause Endothelial Dysfunction on Reperfusion.
-
批准号:07671460
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:ONODA Koji
-
依托单位: